<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00531765</url>
  </required_header>
  <id_info>
    <org_study_id>RAC 2071003</org_study_id>
    <nct_id>NCT00531765</nct_id>
  </id_info>
  <brief_title>Sodium Bicarbonate in Preventing Contrast Induced Nephropathy</brief_title>
  <acronym>SIPCIN</acronym>
  <official_title>Sodium Bicarbonate in Preventing Contrast Induced Nephropathy (SIPCIN): A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King Faisal Specialist Hospital &amp; Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King Faisal Specialist Hospital &amp; Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We plan to conduct an open-label, randomized, stratified, parallel-group study to compare
      normal saline infusion to sodium bicarbonate infusion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We plan to conduct an open-label, randomized, stratified, parallel-group study to compare
      normal saline infusion to sodium bicarbonate infusion. 220 adult patients scheduled for
      routine cardiac catheterization will be enrolled. They will stratified according to the
      presence or absence of DM, or an estimated GER of less than 60 ml/hr before being
      block-randomized to the two groups. The incidence of CIN will be determined based on the
      average of two measurements of creatinine level before and 48 hours after the procedure, and
      an increase of 25% or 0.5 mg/dL (44.2 umol/L) or more.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Contrast Induced nephropathy</measure>
    <time_frame>48 hours</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Contrast Induced Nephropathy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>hydration with normal saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>hydration with sodium bicarbonate</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sodium bicarbonate infusion</intervention_name>
    <description>short infusion of sodium bicarbonate</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All adult patients (18 years and above) who are scheduled for cardiac catechization and
        have abnormal but stable renal function will be eligible for enrollment. Abnormal renal
        function is defined as a creatinine level exceeding the normal range (more than 115 or 96
        um/L in males and females, respectively, in KFSH&amp;RC laboratories) or eGFR less than 60
        ml/min

        Exclusion Criteria:

        Patients who fall under any of the following categories will be excluded:

          -  Acute renal failure

          -  Cardiogenic shock

          -  Emergency cardiac catheterization

          -  Preexisting peritoneal or hemodialysis

          -  Pregnancy

          -  Recent exposure to contrast agent within the last 3 days

          -  Allergy to contrast or any of the above treatment

          -  Renal transplant,

          -  Patients who received dopamine, mannitol, theophyllin or other medications known to
             affect renal function within one week from cardiac cath

          -  Pulmonary edema / congestive heart failure

          -  Use of N-acetylcystein

          -  Patents on NSAIDS who can not stop using them for 48 hrs before and 48 hrs after
             procedure (except Aspirin).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fawaz Al Turki, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>King Faisal Specialist Hospital &amp; Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>King Faisal Specialist Hospital &amp; Research Center</name>
      <address>
        <city>Riyadh</city>
        <zip>11211</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>July 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 17, 2007</study_first_submitted>
  <study_first_submitted_qc>September 17, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2007</study_first_posted>
  <last_update_submitted>July 24, 2010</last_update_submitted>
  <last_update_submitted_qc>July 24, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 27, 2010</last_update_posted>
  <responsible_party>
    <name_title>Fawaz Alturki</name_title>
    <organization>King Faisal Specialist Hospital &amp; Research center</organization>
  </responsible_party>
  <keyword>contrast-induced-nephropathy,</keyword>
  <keyword>cardiac cath</keyword>
  <keyword>creatinine</keyword>
  <keyword>contrast</keyword>
  <keyword>nephropathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

